ArticleAsian Pacific journal of cancer prevention : APJCP2024
Gastric Cancer Survival and Its Predictors in Nepal.
Article in Asian Pacific journal of cancer prevention : APJCP, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The therapeutic potential of targeting LYAR in gastric cancer.Future science OA · 2026Article
- Prognostic value of glycemic variability for ICU and in-hospital all-cause mortality in postoperative patients with upper gastrointestinal cancer: a retrospective cohort study.Frontiers in endocrinology · 2026Article
- SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression.Cell division · 2025Article
- Tumor Characteristics and D2 Lymph Node Involvement in Gastric Cancer: A Clinicopathological Analysis (2018-2023) :.Galen medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundIn Nepal, gastric cancer was the second most common cause of cancer deaths in males and the fifth most common cause of cancer deaths in females in 2020. Although gastric cancer is a significant public health problem, there have been no studies undertaken in Nepal to determine the survival and predictors of gastric cancer survival.
methodsA retrospective cohort study of gastric cancer patients at Bhaktapur Cancer Hospital in Kathmandu Valley, Nepal. Data were analysed from 817 new gastric cancer cases, diagnosed between January 2010 and December 2021. Survival rate was analyzed using Kaplan-Meyer methods, and predictors of gastric cancer survival were analyzed using Cox Regression methods.
resultsThe median overall survival for gastric cancer patients was 19 months since diagnosis. The five-year survival rate was 12%. The predictors for survival were younger age, tumors located in the non-cardia, early stage, treatment by surgery, and treatment by chemotherapy. However, sex, histologic type, tumor grade, tumor subtype, and extent of cancer were not associated with survival.
conclusionIn Nepal, the overall survival of patients with gastric cancer was 12%, which is much lower than in high-income countries. Predictors of survival were patient age at diagnosis, the stage at diagnosis, the location of the tumor, and the treatment undertaken, both in Nepal and in high-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.